Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

Mindfulness-based cognitive therapy for children and adolescents with anxiety disorders at-risk for bipolar disorder: A psychoeducation waitlist controlled pilot trial.

Cotton S, Kraemer KM, Sears RW, Strawn JR, Wasson RS, McCune N, Welge J, Blom TJ, Durling M, Delbello MP.

Early Interv Psychiatry. 2019 Jul 2. doi: 10.1111/eip.12848. [Epub ahead of print]

PMID:
31264800
2.

Pharmacogenetics of Sertraline Tolerability and Response in Pediatric Anxiety and Depressive Disorders.

Poweleit EA, Aldrich SL, Martin LJ, Hahn D, Strawn JR, Ramsey LB.

J Child Adolesc Psychopharmacol. 2019 Jun;29(5):348-361. doi: 10.1089/cap.2019.0017. Epub 2019 May 8.

PMID:
31066578
3.

Longitudinal proton spectroscopy study of the prefrontal cortex in youth at risk for bipolar disorder before and after their first mood episode.

Nery FG, Weber WA, Blom TJ, Welge J, Patino LR, Strawn JR, Chu WJ, Adler CM, Komoroski RA, Strakowski SM, DelBello MP.

Bipolar Disord. 2019 Jun;21(4):330-341. doi: 10.1111/bdi.12770. Epub 2019 Mar 28.

PMID:
30864200
4.

Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders.

Aldrich SL, Poweleit EA, Prows CA, Martin LJ, Strawn JR, Ramsey LB.

Front Pharmacol. 2019 Feb 19;10:99. doi: 10.3389/fphar.2019.00099. eCollection 2019.

5.

CYP2C19-Guided Escitalopram and Sertraline Dosing in Pediatric Patients: A Pharmacokinetic Modeling Study.

Strawn JR, Poweleit EA, Ramsey LB.

J Child Adolesc Psychopharmacol. 2019 Jun;29(5):340-347. doi: 10.1089/cap.2018.0160. Epub 2019 Feb 28.

PMID:
30817183
6.

Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy.

Strawn JR, Mills JA, Croarkin PE.

J Child Adolesc Psychopharmacol. 2019 May;29(4):250-255. doi: 10.1089/cap.2018.0145. Epub 2019 Feb 27.

PMID:
30810350
7.

Efficacy and Tolerability of Pharmacotherapy for Pediatric Anxiety Disorders: A Network Meta-Analysis.

Dobson ET, Bloch MH, Strawn JR.

J Clin Psychiatry. 2019 Jan 29;80(1). pii: 17r12064. doi: 10.4088/JCP.17r12064.

8.

Fluoxetine Modulates Spontaneous and Conditioned Behaviors to Carbon Dioxide (CO2) Inhalation and Alters Forebrain-Midbrain Neuronal Activation.

McMurray KMJ, Strawn JR, Sah R.

Neuroscience. 2019 Jan 1;396:108-118. doi: 10.1016/j.neuroscience.2018.10.042. Epub 2018 Nov 12.

PMID:
30439538
9.

Racial Differences in Escitalopram/Citalopram-Related Weight Gain in Children and Adolescents: A Natural Language Processing-Based Electronic Medical Record Study.

Ramsey LB, Aldrich SL, Poweleit E, Prows CA, Martin LJ, Strawn JR.

J Child Adolesc Psychopharmacol. 2019 Mar;29(2):162-163. doi: 10.1089/cap.2018.0110. Epub 2018 Nov 14. No abstract available.

PMID:
30427735
10.

Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review.

Strawn JR, Geracioti L, Rajdev N, Clemenza K, Levine A.

Expert Opin Pharmacother. 2018 Jul;19(10):1057-1070. doi: 10.1080/14656566.2018.1491966. Review.

11.

Discrete patterns of cortical thickness in youth with bipolar disorder differentially predict treatment response to quetiapine but not lithium.

Zhang W, Xiao Y, Sun H, Patino LR, Tallman MJ, Weber WA, Adler CM, Klein C, Strawn JR, Nery FG, Gong Q, Sweeney JA, Lui S, DelBello MP.

Neuropsychopharmacology. 2018 Oct;43(11):2256-2263. doi: 10.1038/s41386-018-0120-y. Epub 2018 Jun 18.

PMID:
29946107
12.

Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder: Design, Definitions, and Ongoing Challenges for Child and Adolescent Psychopharmacology Research.

Strawn JR, Croarkin PE.

J Child Adolesc Psychopharmacol. 2018 Jun;28(5):363. doi: 10.1089/cap.2018.0012. Epub 2018 Apr 5. No abstract available.

PMID:
29620924
13.

The Impact of Antidepressant Dose and Class on Treatment Response in Pediatric Anxiety Disorders: A Meta-Analysis.

Strawn JR, Mills JA, Sauley BA, Welge JA.

J Am Acad Child Adolesc Psychiatry. 2018 Apr;57(4):235-244.e2. doi: 10.1016/j.jaac.2018.01.015. Epub 2018 Feb 8.

14.

Behavioral interventions as a treatment for epilepsy: A multicenter randomized controlled trial.

Haut SR, Lipton RB, Cornes S, Dwivedi AK, Wasson R, Cotton S, Strawn JR, Privitera M.

Neurology. 2018 Mar 13;90(11):e963-e970. doi: 10.1212/WNL.0000000000005109. Epub 2018 Feb 14.

PMID:
29444968
15.

Antidepressant-Induced Activation in Children and Adolescents: Risk, Recognition and Management.

Luft MJ, Lamy M, DelBello MP, McNamara RK, Strawn JR.

Curr Probl Pediatr Adolesc Health Care. 2018 Feb;48(2):50-62. doi: 10.1016/j.cppeds.2017.12.001. Epub 2018 Jan 19. Review.

16.

Antidepressant Treatment Duration in Pediatric Depressive and Anxiety Disorders: How Long is Long Enough?

Hathaway EE, Walkup JT, Strawn JR.

Curr Probl Pediatr Adolesc Health Care. 2018 Feb;48(2):31-39. doi: 10.1016/j.cppeds.2017.12.002. Epub 2018 Jan 12.

17.

Pharmacogenomic Testing in Child and Adolescent Psychiatry: An Evidence-Based Review.

Wehry AM, Ramsey L, Dulemba SE, Mossman SA, Strawn JR.

Curr Probl Pediatr Adolesc Health Care. 2018 Feb;48(2):40-49. doi: 10.1016/j.cppeds.2017.12.003. Epub 2018 Jan 8. Review.

18.

Individuation for a DSM-5 disorder: Adult separation anxiety.

Strawn JR, Dobson ET.

Depress Anxiety. 2017 Dec;34(12):1082-1084. doi: 10.1002/da.22703. No abstract available.

PMID:
29211944
19.

Suicidality in psychiatrically hospitalized children and adolescents: Demographics, treatment, and outcome.

Dobson ET, Keeshin BR, Wehry AM, Saldaña SN, Mukkamala LR, Sorter MT, DelBello MP, Blom TJ, Strawn JR.

Ann Clin Psychiatry. 2017 Nov;29(4):258-265.

20.

The Generalized Anxiety Disorder 7-item scale in adolescents with generalized anxiety disorder: Signal detection and validation.

Mossman SA, Luft MJ, Schroeder HK, Varney ST, Fleck DE, Barzman DH, Gilman R, DelBello MP, Strawn JR.

Ann Clin Psychiatry. 2017 Nov;29(4):227-234A.

21.

Buspirone in Children and Adolescents with Anxiety: A Review and Bayesian Analysis of Abandoned Randomized Controlled Trials.

Strawn JR, Mills JA, Cornwall GJ, Mossman SA, Varney ST, Keeshin BR, Croarkin PE.

J Child Adolesc Psychopharmacol. 2018 Feb;28(1):2-9. doi: 10.1089/cap.2017.0060. Epub 2017 Aug 28. Review.

22.

Use of Prazosin for Pediatric PTSD-Associated Nightmares and Sleep Disturbances: A Retrospective Chart Review.

Keeshin BR, Ding Q, Presson AP, Berkowitz SJ, Strawn JR.

Neurol Ther. 2017 Dec;6(2):247-257. doi: 10.1007/s40120-017-0078-4. Epub 2017 Jul 28.

23.

Acid-sensing T cell death associated gene-8 receptor expression in panic disorder.

Strawn JR, Vollmer LL, McMurray KMJ, Mills JA, Mossman SA, Varney ST, Schroeder HK, Sah R.

Brain Behav Immun. 2018 Jan;67:36-41. doi: 10.1016/j.bbi.2017.07.014. Epub 2017 Jul 20.

24.

Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non-Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update.

Kris MG, Gaspar LE, Chaft JE, Kennedy EB, Azzoli CG, Ellis PM, Lin SH, Pass HI, Seth R, Shepherd FA, Spigel DR, Strawn JR, Ung YC, Weyant M.

J Clin Oncol. 2017 Sep 1;35(25):2960-2974. doi: 10.1200/JCO.2017.72.4401. Epub 2017 Apr 24. Review.

PMID:
28437162
25.

Placebo Response in Pediatric Anxiety Disorders: Results from the Child/Adolescent Anxiety Multimodal Study.

Strawn JR, Dobson ET, Mills JA, Cornwall GJ, Sakolsky D, Birmaher B, Compton SN, Piacentini J, McCracken JT, Ginsburg GS, Kendall PC, Walkup JT, Albano AM, Rynn MA.

J Child Adolesc Psychopharmacol. 2017 Aug;27(6):501-508. doi: 10.1089/cap.2016.0198. Epub 2017 Apr 6.

26.

Extended Release Guanfacine in Pediatric Anxiety Disorders: A Pilot, Randomized, Placebo-Controlled Trial.

Strawn JR, Compton SN, Robertson B, Albano AM, Hamdani M, Rynn MA.

J Child Adolesc Psychopharmacol. 2017 Feb;27(1):29-37. doi: 10.1089/cap.2016.0132. Epub 2017 Feb 6.

27.

Antidepressant Prescribing by Pediatricians: A Mixed-Methods Analysis.

Tulisiak AK, Klein JA, Harris E, Luft MJ, Schroeder HK, Mossman SA, Varney ST, Keeshin BR, Cotton S, Strawn JR.

Curr Probl Pediatr Adolesc Health Care. 2017 Jan;47(1):15-24. doi: 10.1016/j.cppeds.2016.11.009. Epub 2017 Jan 2.

28.

Primary Pediatric Care Psychopharmacology: Focus on Medications for ADHD, Depression, and Anxiety.

Strawn JR, Dobson ET, Giles LL.

Curr Probl Pediatr Adolesc Health Care. 2017 Jan;47(1):3-14. doi: 10.1016/j.cppeds.2016.11.008. Epub 2016 Dec 30. Review.

29.

White matter volumes in youth offspring of bipolar parents.

Nery FG, Norris M, Eliassen JC, Weber WA, Blom TJ, Welge JA, Barzman DA, Strawn JR, Adler CM, Strakowski SM, DelBello MP.

J Affect Disord. 2017 Feb;209:246-253. doi: 10.1016/j.jad.2016.11.023. Epub 2016 Nov 25.

PMID:
27936454
30.

Familial risk for bipolar disorder is not associated with impaired peroxisomal function: Dissociation from docosahexaenoic acid deficits.

McNamara RK, Moser AB, Jones RI, Jandacek R, Patino LR, Strawn JR, Strakowski SM, DelBello MP.

Psychiatry Res. 2016 Dec 30;246:803-807. doi: 10.1016/j.psychres.2016.10.042. Epub 2016 Oct 25.

31.

Neurofunctional Differences Among Youth With and at Varying Risk for Developing Mania.

Welge JA, Saliba LJ, Strawn JR, Eliassen JC, Patino LR, Adler CM, Weber W, Schneider MR, Barzman DH, Strakowski SM, DelBello MP, McNamara RK.

J Am Acad Child Adolesc Psychiatry. 2016 Nov;55(11):980-989. doi: 10.1016/j.jaac.2016.08.006. Epub 2016 Sep 13.

PMID:
27806866
32.

fMRI brain activation changes following treatment of a first bipolar manic episode.

Strakowski SM, Fleck DE, Welge J, Eliassen JC, Norris M, Durling M, Komoroski RA, Chu WJ, Weber W, Dudley JA, Blom TJ, Stover A, Klein C, Strawn JR, DelBello MP, Lee JH, Adler CM.

Bipolar Disord. 2016 Sep;18(6):490-501. doi: 10.1111/bdi.12426. Epub 2016 Sep 19.

33.

Pharmacologic Treatment of Pediatric Anxiety Disorders.

Hussain FS, Dobson ET, Strawn JR.

Curr Treat Options Psychiatry. 2016 Jun;3(2):151-160. Epub 2016 Apr 22.

34.

Psychopharmacologic Management of Anxiety in an Adolescent with Congenital Long QT Syndrome.

Minton TB, Rosing J, Spar DS, Strawn JR, Garcia-Delgar B, Coffey BJ.

J Child Adolesc Psychopharmacol. 2016 Jun;26(5):485-9. doi: 10.1089/cap.2016.29109.bjc. Epub 2016 Jun 10. No abstract available.

35.

Comorbid Anxiety and Depressive Symptoms in Children and Adolescents: A Systematic Review and Analysis.

Melton TH, Croarkin PE, Strawn JR, McClintock SM.

J Psychiatr Pract. 2016 Mar;22(2):84-98. doi: 10.1097/PRA.0000000000000132. Review.

36.

Placebo Response in Pediatric Anxiety Disorders: Implications for Clinical Trial Design and Interpretation.

Dobson ET, Strawn JR.

J Child Adolesc Psychopharmacol. 2016 Oct;26(8):686-693. Epub 2016 Mar 30.

37.

Neural Function Before and After Mindfulness-Based Cognitive Therapy in Anxious Adolescents at Risk for Developing Bipolar Disorder.

Strawn JR, Cotton S, Luberto CM, Patino LR, Stahl LA, Weber WA, Eliassen JC, Sears R, DelBello MP.

J Child Adolesc Psychopharmacol. 2016 May;26(4):372-9. doi: 10.1089/cap.2015.0054. Epub 2016 Jan 19.

38.

Pharmacotherapy for Pediatric Generalized Anxiety Disorder: A Systematic Evaluation of Efficacy, Safety and Tolerability.

Dobson ET, Strawn JR.

Paediatr Drugs. 2016 Feb;18(1):45-53. doi: 10.1007/s40272-015-0153-1. Review.

39.

Adolescents with or at ultra-high risk for bipolar disorder exhibit erythrocyte docosahexaenoic acid and eicosapentaenoic acid deficits: a candidate prodromal risk biomarker.

McNamara RK, Jandacek R, Tso P, Blom TJ, Welge JA, Strawn JR, Adler CM, Strakowski SM, DelBello MP.

Early Interv Psychiatry. 2016 Jun;10(3):203-11. doi: 10.1111/eip.12282. Epub 2015 Oct 20.

40.

First-episode bipolar disorder is associated with erythrocyte membrane docosahexaenoic acid deficits: Dissociation from clinical response to lithium or quetiapine.

McNamara RK, Jandacek R, Tso P, Blom TJ, Welge JA, Strawn JR, Adler CM, DelBello MP, Strakowski SM.

Psychiatry Res. 2015 Dec 15;230(2):447-53. doi: 10.1016/j.psychres.2015.09.035. Epub 2015 Oct 9.

41.

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.

Masters GA, Temin S, Azzoli CG, Giaccone G, Baker S Jr, Brahmer JR, Ellis PM, Gajra A, Rackear N, Schiller JH, Smith TJ, Strawn JR, Trent D, Johnson DH; American Society of Clinical Oncology Clinical Practice.

J Clin Oncol. 2015 Oct 20;33(30):3488-515. doi: 10.1200/JCO.2015.62.1342. Epub 2015 Aug 31. Erratum in: J Clin Oncol. 2016 Apr 10;34(11):1287.

42.

Childhood trauma in patients with self-reported stress-precipitated seizures.

Lee I, Strawn JR, Dwivedi AK, Walters M, Fleck A, Schwieterman D, Haut SR, Polak E, Privitera M.

Epilepsy Behav. 2015 Oct;51:210-4. doi: 10.1016/j.yebeh.2015.07.019. Epub 2015 Aug 24.

PMID:
26295447
43.

Acid-base dysregulation and chemosensory mechanisms in panic disorder: a translational update.

Vollmer LL, Strawn JR, Sah R.

Transl Psychiatry. 2015 May 26;5:e572. doi: 10.1038/tp.2015.67. Review.

44.

Assessment and treatment of anxiety disorders in children and adolescents.

Wehry AM, Beesdo-Baum K, Hennelly MM, Connolly SD, Strawn JR.

Curr Psychiatry Rep. 2015 Jul;17(7):52. doi: 10.1007/s11920-015-0591-z. Review.

45.

Neurostructural abnormalities in pediatric anxiety disorders.

Strawn JR, Hamm L, Fitzgerald DA, Fitzgerald KD, Monk CS, Phan KL.

J Anxiety Disord. 2015 May;32:81-8. doi: 10.1016/j.janxdis.2015.03.004. Epub 2015 Mar 17.

46.

Elevated salivary alpha amylase in adolescent sexual abuse survivors with posttraumatic stress disorder symptoms.

Keeshin BR, Strawn JR, Out D, Granger DA, Putnam FW.

J Child Adolesc Psychopharmacol. 2015 May;25(4):344-50. doi: 10.1089/cap.2014.0034. Epub 2015 Mar 24.

47.

A randomized, placebo-controlled study of duloxetine for the treatment of children and adolescents with generalized anxiety disorder.

Strawn JR, Prakash A, Zhang Q, Pangallo BA, Stroud CE, Cai N, Findling RL.

J Am Acad Child Adolesc Psychiatry. 2015 Apr;54(4):283-93. doi: 10.1016/j.jaac.2015.01.008. Epub 2015 Jan 29.

PMID:
25791145
48.

Neurobiology of Pediatric Anxiety Disorders.

Strawn JR, Dominick KC, Patino LR, Doyle CD, Picard LS, Phan KL.

Curr Behav Neurosci Rep. 2014 Sep 1;1(3):154-160.

49.

The effects of lacosamide on depression and anxiety in patients with epilepsy.

Moseley BD, Cole D, Iwuora O, Strawn JR, Privitera M.

Epilepsy Res. 2015 Feb;110:115-8. doi: 10.1016/j.eplepsyres.2014.12.007. Epub 2014 Dec 15.

PMID:
25616463
50.

Mindfulness-based cognitive therapy for youth with anxiety disorders at risk for bipolar disorder: a pilot trial.

Cotton S, Luberto CM, Sears RW, Strawn JR, Stahl L, Wasson RS, Blom TJ, Delbello MP.

Early Interv Psychiatry. 2016 Oct;10(5):426-34. doi: 10.1111/eip.12216. Epub 2015 Jan 13.

PMID:
25582800

Supplemental Content

Loading ...
Support Center